Skip to main content

Table 2 Summary of Average Acceptance

From: Acceptance of oclacitinib maleate (Apoquel®) chewable tablets in client-owned dogs with allergic and atopic dermatitis

Acceptance Rate

Total Number

Overall Rate

Overall Voluntary Acceptance within 5 min

1533

91.6%

Overall Consumption with Assistancea

134

8.0%

Overall Non-consumption

6

0.4%

  1. a If the dog did not fully consume the offered dose within 5 min, the remaining tablet(s) were administered in food, treat or by pilling